VOLPI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 23.079
EU - Europa 1.946
AS - Asia 759
AF - Africa 58
SA - Sud America 50
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.945
Nazione #
US - Stati Uniti d'America 23.015
CN - Cina 419
UA - Ucraina 347
IT - Italia 338
DE - Germania 296
IE - Irlanda 204
FR - Francia 183
PL - Polonia 130
GB - Regno Unito 113
SE - Svezia 106
KR - Corea 96
FI - Finlandia 72
CA - Canada 47
IN - India 46
RU - Federazione Russa 39
BE - Belgio 37
JP - Giappone 36
EG - Egitto 35
AU - Australia 33
VN - Vietnam 30
BR - Brasile 28
ID - Indonesia 24
RO - Romania 21
TR - Turchia 20
NO - Norvegia 16
NZ - Nuova Zelanda 16
NL - Olanda 14
SG - Singapore 13
HK - Hong Kong 12
MX - Messico 11
SA - Arabia Saudita 11
ES - Italia 10
PH - Filippine 8
IL - Israele 7
AR - Argentina 6
CL - Cile 6
LR - Liberia 6
PK - Pakistan 6
TH - Thailandia 6
ZA - Sudafrica 5
GR - Grecia 4
IR - Iran 4
MY - Malesia 4
VE - Venezuela 4
AT - Austria 3
CH - Svizzera 3
ET - Etiopia 3
KG - Kirghizistan 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EC - Ecuador 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
PE - Perù 2
PR - Porto Rico 2
UG - Uganda 2
UZ - Uzbekistan 2
AM - Armenia 1
BD - Bangladesh 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 25.945
Città #
Woodbridge 6.995
Wilmington 6.246
Houston 6.066
Ann Arbor 559
Fairfield 476
Chandler 362
Ashburn 327
Jacksonville 307
Seattle 199
Dublin 194
Dearborn 184
Zhengzhou 176
Cambridge 174
Medford 144
Kraków 126
Beijing 125
Rome 90
Lawrence 70
New York 61
Redwood City 55
Mülheim 49
Shanghai 38
Milan 37
Menlo Park 30
San Diego 28
Brussels 23
London 19
Boardman 18
Bergen 15
Seongnam 15
Dong Ket 14
Mountain View 13
University Park 13
Verona 13
Melbourne 12
Norwalk 12
Phoenix 12
Hefei 11
Hanoi 10
Izmir 9
Mumbai 9
Palo Alto 9
Sydney 9
Nanjing 8
Ottawa 8
Pune 8
Falls Church 7
Guangzhou 7
Jakarta 7
Napoli 7
Palermo 7
Toronto 7
Bangalore 6
Bucharest 6
Ho Chi Minh City 6
Naples 6
Saint Petersburg 6
San Mateo 6
Auburn Hills 5
Bethesda 5
Birmingham 5
Codó 5
Helsinki 5
Renton 5
Rio de Janeiro 5
Riyadh 5
Schepdaal 5
Seoul 5
Auckland 4
Bandung 4
Hangzhou 4
Indiana 4
Kunming 4
Maturín 4
Orbassano 4
Pont-Canavese 4
Rochester 4
Vadodara 4
Yokohama 4
Austin 3
Bangkok 3
Bengaluru 3
Bologna 3
Boston 3
Brisbane 3
Buffalo 3
Bursa 3
Colchester 3
Dinalupihan 3
Fuzhou 3
Guidonia 3
Halifax 3
Hounslow 3
Isernia 3
Kuala Lumpur 3
Liverpool 3
Marzabotto 3
Montreal 3
Newark 3
Plogoff 3
Totale 23.613
Nome #
Severe complications of herpes zoster 1.171
Transmission of human herpesvirus 8: An update 474
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 472
No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia 470
Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated Herpes virus in BCBL-1 cells 463
Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells 452
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 435
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 421
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 418
Reducing the burden of Herpes Zoster in Italy. 417
One-year follow-up of patients with long-lasting post-herpetic neuralgia 414
A Systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication 408
Clinical and psychosocial correlates of acute pain in herpes zoster 407
Preventing and managing herpes zoster: key actions to foster healthy aging 407
Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients 406
Reducing the burden of Herpes Zoster in Italy. 402
Current management of herpes zoster: The European view 401
Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients 400
Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster 397
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy 395
Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study 395
Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience 393
Frequency of herpes zoster recurrence 391
5(2-bromovinyl)-2’-deoxyuridine (BVDU), increases the amount of chromatid breaks induced by bleomycin in mismatch repair deficient tumor cells by inhibiting homologous recombination 391
Clinical and psychosocial correlates of post-herpetic neuralgia 383
Virus dell’Herpes Simplex. 383
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. 381
Effect of extremely low frequency electromagnetic fields (ELF-EMF) on Kaposi's sarcoma-associated herpes virus in BCBL-1 cells 381
Herpes Zoster and its prevention in Italy. Scientific consensus statement 381
Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers 378
Role of DNA repair pathways in the control of common fragile sites expression. 377
Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients. 377
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 376
Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes 375
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract 373
Public awareness and knowledge of herpes labialis 370
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 370
Anticorpi per HHV8 in pazienti con infezione da HIV. 368
DNA damaging agents can induce celll cycle arrest in different phases of mitosis 366
Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis 359
Cidofovir on HHV-8 in BCBL-1 cells 358
Aciclovir, herpes viruses and HIV: a never-ending story 357
Un caso di riattivazione contemporanea della infezione da virus Herpes Simplex 1 e 2 in seguito a trapianto di rene. vol. 37, p. 983-984 354
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults 354
Indagine preliminare sulla storia naturale dell'infezione da Citomegalovirus nell'infanzia 352
Prevalenza di marcatori sierologici dell'infezione da rosolia e da citomegalovirus nel personale femminile degli asili nido. vol. 3, p. 63-65 351
Direct diagnosis of HSV Infections. vol. 5, p. 31-32 347
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 347
Indagini sulla reattività anticorpale per Citomegalovirus nel morbo di Sjogren. vol. 37, p. 1014-1015 342
null 338
null 332
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009¿2010): a GP-based prospective cohort study. 331
Herpes genitale in gravidanza. vol. 23, p. 2-4 330
Management of herpes zoster and post-herpetic neuralgia now and in the future 329
Role of NGF on cell survival and virus maturation in HHV-8-infected primary effusion lymphoma cells. 329
L'infezione da Citomegalovirus (CMV) in patologia umana. , vol. Numero 0 - Anno 1, p. 38-41 327
DNA repair defects and chromosomal fragile sites expression. 320
Infezione da Citomegalovirus di cellule linfomonocitarie. vol. 37, p. 1012-1013 320
Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy 319
Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. 315
Le infezioni correlate all'assistenza e l'antibioticoresistenza: una sfida globale del XXI secolo 310
Differential effects on mitosis of DNA damaging agents with distinct mechanisms 308
Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010 306
[Ebola Virus Disease (EVD): proposed guideline for hospital triage of suspect and probable cases] 297
Effect of the BH3 mimetic polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo growth of malignant mesothelioma 292
Epstein-Barr virus and CNS infectionjs 288
La gestione del paziente con Herpes zoster. p. 10-15, ISSN: 0390-0347 264
HEALTHCARE ASSOCIATED INFECTIONSImpact of Diagnosis and Management of Clostridium Difficile Infections (CDI)The Experience of a University Hospital in Rome 202
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy 131
Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies 127
La Terza Missione dell'Università: formazione e salute 34
Malattia da Virus Ebola (MVE): proposta di linea guida per il triage ospedaliero dei casi sospetti e probabili 16
Homologous recombination but not poly(adp-ribose) polymerase-1 is involved in the control of common fragile sites stability 7
Totale 26.132
Categoria #
all - tutte 41.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.858 0 0 0 0 0 0 0 0 0 591 652 615
2019/20206.969 551 550 502 614 561 773 587 596 620 557 508 550
2020/20214.269 472 502 470 534 444 486 531 417 119 78 165 51
2021/2022794 23 102 57 51 34 54 39 54 51 76 47 206
2022/20231.133 100 97 24 149 94 235 97 70 103 19 112 33
2023/2024516 64 26 23 40 70 164 34 55 28 12 0 0
Totale 26.132